IU vs 100 IU · women undergoing IVF/ICSI who are anticipated to have a hyper‐response to stimulation based on at least one ORT measure
Anticipated high responders: higher showed no clear difference in IU vs 100 IU compared with lower dose of FSH (low certainty).
1 finding from 1 review
OHSS · Women undergoing IVF/ICSI cycles
ORT‐based algorithm showed no clear difference in OHSS compared with standard starting dose of FSH (low certainty).
1 finding from 1 review
Clinical pregnancy · Women undergoing IVF/ICSI cycles
ORT‐based algorithm showed no clear difference in clinical pregnancy compared with standard starting dose of FSH (low certainty).
1 finding from 1 review
300/450 IU vs 150 IU · women undergoing IVF/ICSI who are anticipated to have a low‐response to stimulation based on one or more ORT measure
Anticipated low responders: higher showed no clear difference in 300/450 IU vs 150 IU compared with lower dose of FSH (low certainty).
1 finding from 1 review
400/450 IU vs 300 IU · women undergoing IVF/ICSI who are anticipated to have a low‐response to stimulation based on one or more ORT measure
Anticipated low responders: higher showed no clear difference in 400/450 IU vs 300 IU compared with lower dose of FSH (low certainty).
1 finding from 1 review
IU vs 450 IU · women undergoing IVF/ICSI who are anticipated to have a low‐response to stimulation based on one or more ORT measure
Anticipated low responders: higher showed no clear difference in IU vs 450 IU compared with lower dose of FSH (low certainty).
1 finding from 1 review
IU vs 100 IU · women undergoing IVF/ICSI who are anticipated to have a normal response to stimulation based on at least one ORT measure
Anticipated normal responders: higher showed no clear difference in IU vs 100 IU compared with lower dose of FSH (low certainty).
1 finding from 1 review
225/200 IU vs 150 IU · women undergoing IVF/ICSI who are anticipated to have a normal response to stimulation based on at least one ORT measure
Anticipated normal responders: higher showed no clear difference in 225/200 IU vs 150 IU compared with lower dose of FSH (low certainty).
1 finding from 1 review
IU vs 225 IU · women undergoing IVF/ICSI who are anticipated to have a normal response to stimulation based on at least one ORT measure
Anticipated normal responders: higher showed no clear difference in IU vs 225 IU compared with lower dose of FSH (low certainty).
1 finding from 1 review
Live birth or ongoing pregnancy · women undergoing assisted reproduction
It is very uncertain whether intrauterine injection of autologous platelet‐rich plasma changes live birth (or ongoing pregnancy) compared with no intervention (very low certainty).
1 finding from 1 review
Adverse events: preterm delivery · women undergoing assisted reproduction
Intrauterine infusion/injection of autologous platelet‐rich plasma may leads to higher adverse events: preterm delivery compared with no intervention or placebo (low certainty).
1 finding from 1 review
Live birth or ongoing pregnancy · women undergoing assisted reproduction
It is very uncertain whether intrauterine infusion of autologous platelet‐rich plasma changes live birth (or ongoing pregnancy compared with intrauterine infusion of granulocyte colony‐stimulating factor (very low certainty).
1 finding from 1 review
Miscarriage · women undergoing assisted reproduction
It is very uncertain whether intrauterine infusion of autologous platelet‐rich plasma changes miscarriage compared with intrauterine infusion of granulocyte colony‐stimulating factor (very low certainty).
1 finding from 1 review
Clinical pregnancy · women undergoing assisted reproduction
It is very uncertain whether intrauterine infusion of autologous platelet‐rich plasma changes clinical pregnancy compared with intrauterine infusion of granulocyte colony‐stimulating factor (very low certainty).
1 finding from 1 review
Adverse events · women undergoing assisted reproduction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Ongoing pregnancy · women undergoing assisted reproduction
It is very uncertain whether intraovarian injection of autologous platelet‐rich plasma changes ongoing pregnancy compared with no intervention (very low certainty).
1 finding from 1 review
Miscarriage · women undergoing assisted reproduction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical pregnancy · women undergoing assisted reproduction
It is very uncertain whether intraovarian injection of autologous platelet‐rich plasma changes clinical pregnancy compared with no intervention (very low certainty).
1 finding from 1 review
Adverse events · women undergoing assisted reproduction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Miscarriage · women undergoing assisted reproduction
It is very uncertain whether intrauterine injection of autologous platelet‐rich plasma changes miscarriage compared with no intervention (very low certainty).
1 finding from 1 review